Ikarian Capital, LLC Ac Immune Sa Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.2 - $8.34 $1.22 Million - $1.64 Million
-196,208 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.04 - $8.37 $461,486 - $639,509
76,405 Added 63.78%
196,208 $1.56 Million
Q1 2021

May 17, 2021
BUY
$5.32 - $8.96 $637,351 - $1.07 Million
119,803 New
119,803 $911,000

Others Institutions Holding ACIU

# of Institutions
48
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $220M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email